ARTICLE | Company News
Karo Bio, Pfizer deal
January 2, 2012 8:00 AM UTC
Karo partnered with Pfizer to discover and develop small molecule RAR-related orphan receptor C ( RORC; RORgamma; RORgammaT) modulators to treat autoimmune diseases. Pfizer gains exclusive rights to...